相关实验视频
Updated: Jan 17, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
通过血膜胆固醇重塑,27-氧胆固醇会加剧肝脏的胰岛素抵抗
Jinni Yang1, Xue Yang2, Yuan Zheng2
1Department of Pharmacy, Nanjing Drum Tower Hospital, College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China; Key Laboratory of Drug Quality Control & Pharmacovigilance (China Pharmaceutical University), Ministry of Educational, Nanjing, 210009, China.
高水平的27-胆固醇 (27HC) 通过破坏胆固醇代谢和胰岛素受体功能,损害胰岛素敏感性. 抑制酶CYP27A1显示出治疗胰岛素抵抗的前景.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 胆固醇的新陈代谢
- 胰岛素耐药性 胰岛素耐药性是一种
背景情况:
- 胰岛素抵抗是代谢障碍的主要原因之一,其潜在的分子机制尚未完全理解.
- 27-胆固醇 (27HC),一种由胆固醇衍生的代谢物,与代谢功能障碍有关.
研究的目的:
- 确定27HC是胰岛素抵抗的一个关键因素.
- 研究27HC对胰岛素耐药性的分子机制.
- 探索CYP27A1作为胰岛素抵抗治疗点.
主要方法:
- 在患者和动物模型中使用向代谢学方法量化27HC水平.
- 利用胰岛素抵抗性小鼠模型和各种肝细胞类型进行功能分析.
- 通过转录组学和基于细胞的测定,评估了27HC对胰岛素受体 (IR) 分布和信号通路的影响.
主要成果:
- 在患有代谢功能障碍相关的脂肪性肝病 (MASLD) 患者和肥胖/糖尿病小鼠中,27HC水平升高与胰岛素敏感性受损相关.
- 27HC通过耗尽血膜胆固醇来破坏胰岛素信号传递,导致胰岛素受体 (IR) 错位.
- 对CYP27A1的肝脏特异性沉默改善了小鼠的胰岛素敏感性和代谢平衡.
结论:
- 27HC是胆固醇代谢和胰岛素抵抗之间的关键联系.
- 抑制CYP27A1代表了管理胰岛素耐药性的潜在治疗策略.
相关概念视频
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Pancreatitis II: Collaborative Care
Assessment:
Hepatic Drug Excretion: Influencing Factors

